HEALTH● LOWJul 13 · Jul 13, 2026, 7:15 AM
Faron Pharmaceuticals : Faron Provides Update on Investigator - Initiated Trial Portfolio for Bexmarilimab
finanznachrichten.de · Germany
Faron Pharmaceuticals has provided an update on its portfolio of investigator-initiated trials for the drug Bexmarilimab. This concerns ongoing research and development within the pharmaceutical sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Germany
POLITICS4h agoGermany expels 21-year-old Russian citizen of Yazidi descent who narrowly avoided deportation to Russia, where activists say he risked conscriptionMeduza [en]POLITICS8h agoGermany’s Merz vows to fight on: ‘We are the firewall’Financial TimesPOLITICS9h agoHamburg court sentences Iranian agents over plans to attack Jewish leaders in GermanyDW News [en]POLITICS10h agoWhat you need to know about Germany’s planned tax on sugary drinksEuroNews [en]
More in Health
HEALTH19m agoKerala State Drugs Control dept. seeks curbs on inter-State drug procurement to ensure traceabilityThe HinduHEALTH34m ago93% of children affected by diphtheria outbreaks not fully vaccinated – OfficialPremium TimesHEALTH37m agoDr. Sandra G. Martín, dentist: "Health always comes before a pretty tooth. First biology and then aesthetics. The important thing is that everything is healthy."ClarínHEALTH1h agoMore workers are skipping doctor's visits over money worriesCBS News